GENPHARMA
NSE: GENPHARMA

Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Key Statistics

Investment Rating

  • Master Rating:
  • Genpharmasec has an operating revenue of Rs. 26.09 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of -2% needs improvement, ROE of -1% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a FAIR score but needs to improve its earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 65 indicates it belongs to a poor industry group of Elec-Misc Products and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Synopsis

BSE-Elec-Misc Products

Generic Pharmasec belongs to the Industry of Dyes & Pigments. Company’s Total Operating Revenue is Rs. 21.31 Cr. and Equity Capital is Rs. 27.69 Cr. for the Year ended 31/03/2021. Generic Pharmasec Ltd. is a Public Limited Listed company incorporated on 16/11/1992 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231MH1992PLC323914 and registration number is 018572.
  • Market Cap
  • 107
  • Sales
  • 26
  • Shares in Float
  • 11.07
  • No of funds
  • 1
  • Yield
  • Book Value
  • 6.93
  • U/D Vol ratio
  • 0.4
  • LTDebt / Equity
  • Alpha
  • -0.25
  • Beta
  • 0.66

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 59.96%
  • 59.96%
  • 59.96%
  • Foreign Portfolio Investors
  • Individual Investors
  • 30.36%
  • 30.02%
  • 26.18%
  • Others
  • 9.68%
  • 10.02%
  • 13.86%

Management

  • Name
  • Designation
  • Mr. Ulhas Narayan Deosthale
  • WholeTime Director & CFO
  • Mrs. Sneha Sadhwani
  • Non Executive Director
  • Mr. Rajesh Sadhwani
  • Non Executive Director
  • Mr. Amisha Dani
  • Ind. Non-Executive Director
  • Ms. Nikhita Pais
  • Ind. Non-Executive Director
  • Mr. Yogesh Arvindbhai Bhuva
  • Ind. Non-Executive Director

Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

FAQs

What is Share Price of ?

share price is ₹ As on 20 August, 2022 | 08:10

Q1FY23